Bellicum Pharmaceuticals, Inc. (BLCM) .
本页证实的标准:
SharesGrow 综合评分： 45/100 其中 1/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2013 | $-8.11 | $1.94M | $-7.97M | -410.6% |
| 2014 | $-33.47 | $1.78M | $-83.97M | -4717.1% |
| 2015 | $-18.43 | $282K | $-48.55M | -17215.6% |
| 2016 | $-25.69 | $388K | $-69.24M | -17845.6% |
| 2017 | $-28.94 | $185K | $-91.78M | -49610.3% |
| 2018 | $-24.37 | $1.12M | $-98.04M | -8753.2% |
| 2019 | $-26.92 | $7.14M | $-126.09M | -1765.3% |
| 2020 | $-1.50 | $500K | $-8.62M | -1723.8% |
| 2021 | $-0.83 | $6.2M | $-9.58M | -154.5% |
| 2022 | $-0.81 | $1.5M | $-24.97M | -1664.9% |
